US Patent 7326716 Treatment of inflammatory bowel disease
Patent 7326716 was granted and assigned to Allergan, Inc. on February, 2008 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 7326716 Treatment of inflammatory bowel disease
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
